The MWAC Facility maintains an ever-expanding stock of commercial antibodies intended for diverse research applications that have been validated for use with the MWAC methodology. These antibodies cover a wide range of protein targets and cellular signal transduction pathways conducive to a variety of studies including: network building, pathological marker screens, and drug target identification.
Users are also welcome to include their own antibodies for study on the MWA platform, provided pre-screen criteria are met.
Microwestern Array Core Facility (MWAC)
The University of Chicago
Knapp Center for Biomedical Discovery
900 E. 57th St. Chicago, IL 60637